fevipiprant inn code name drug developed novartis selective orally available antagonist prostaglandin receptor phase clinical trials treatment december switzerlandbased novartis officially announced jettisoning fevipiprant development program given medicine failed two additional clinical trials patients moderatetosevere asthma firm said hoped fevipiprant would billiondollarselling asthma drug article relating respiratory system stub help wikipedia expanding ithttpsenwikipediaorgwikifevipiprant